Compounds > 4-(5-benzo(1-3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide

4-(5-benzo(1-3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide and Fibrosarcoma

4-(5-benzo(1-3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide has been researched along with Fibrosarcoma* in 1 studies

Other Studies

1 other study(ies) available for 4-(5-benzo(1-3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide and Fibrosarcoma

ArticleYear
TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B-T cell axis and decreases tumour burden in murine fibrosarcoma.
    Cancer immunology, immunotherapy : CII, 2021, Volume: 70, Issue:1

    Topics: Animals; Antigens, CD; B-Lymphocytes, Regulatory; Benzamides; Cell Proliferation; Dioxoles; Female; Fibrosarcoma; Forkhead Transcription Factors; Interleukin-10; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Receptors, Transforming Growth Factor beta; Spleen; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tumor Burden

2021